Harald Polzer

1.1k total citations
9 papers, 141 citations indexed

About

Harald Polzer is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Harald Polzer has authored 9 papers receiving a total of 141 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 4 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Harald Polzer's work include Acute Myeloid Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Histone Deacetylase Inhibitors Research (3 papers). Harald Polzer is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Histone Deacetylase Inhibitors Research (3 papers). Harald Polzer collaborates with scholars based in Germany and New Zealand. Harald Polzer's co-authors include Karsten Spiekermann, Hanna Janke, Oliver H. Krämer, Gesine Bug, Marion Subklewe, Friederike Pastore, Marc Buchwald, Karl‐Peter Hopfner, Stephanie Schneider and Stefan K. Bohlander and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Harald Polzer

8 papers receiving 141 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harald Polzer Germany	6	111	83	39	18	13	9	141
Y. Lucy Liu United States	6	97 0.9×	102 1.2×	52 1.3×	15 0.8×	14 1.1×	15	153
Kristen Meldi United States	4	111 1.0×	112 1.3×	41 1.1×	12 0.7×	15 1.2×	6	166
Evan Massi United States	3	116 1.0×	75 0.9×	40 1.0×	12 0.7×	12 0.9×	3	134
Kalyan Nadiminti United States	6	68 0.6×	65 0.8×	18 0.5×	24 1.3×	6 0.5×	24	115
Elżbieta Patkowska Poland	7	90 0.8×	44 0.5×	36 0.9×	17 0.9×	22 1.7×	22	114
Laura Scifo United Kingdom	2	64 0.6×	123 1.5×	30 0.8×	24 1.3×	6 0.5×	3	152
Konstanze Doehner Germany	4	41 0.4×	68 0.8×	13 0.3×	18 1.0×	9 0.7×	14	101
Hanna Janke Germany	3	127 1.1×	69 0.8×	48 1.2×	9 0.5×	31 2.4×	4	136
Matthieu Duchmann France	4	61 0.5×	46 0.6×	26 0.7×	7 0.4×	10 0.8×	11	92
Stefanie Alzate France	6	60 0.5×	61 0.7×	30 0.8×	24 1.3×	12 0.9×	7	83

Countries citing papers authored by Harald Polzer

Since Specialization

Citations

This map shows the geographic impact of Harald Polzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harald Polzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harald Polzer more than expected).

Fields of papers citing papers by Harald Polzer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harald Polzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harald Polzer. The network helps show where Harald Polzer may publish in the future.

Co-authorship network of co-authors of Harald Polzer

This figure shows the co-authorship network connecting the top 25 collaborators of Harald Polzer. A scholar is included among the top collaborators of Harald Polzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harald Polzer. Harald Polzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Sellmer, Andreas, Mandy Beyer, Herwig Pongratz, et al.. (2020). A series of novel aryl-methanone derivatives as inhibitors of FMS-like tyrosine kinase 3 (FLT3) in FLT3-ITD-positive acute myeloid leukemia. European Journal of Medicinal Chemistry. 193. 112232–112232. 14 indexed citations

Bauer, Julia, Katrin Reiter, Annika Dufour, et al.. (2016). The new and recurrent FLT3 juxtamembrane deletion mutation shows a dominant negative effect on the wild-type FLT3 receptor. Scientific Reports. 6(1). 28032–28032. 10 indexed citations

Sironi, Silvia, Michaela Wagner, Harald Polzer, et al.. (2015). Microenvironmental Hypoxia regulates FLT3 expression and biology in AML. Scientific Reports. 5(1). 17550–17550. 14 indexed citations

Reiter, Katrin, Harald Polzer, Christina Krupka, et al.. (2015). Tyrosin Kinase Inhibition Restores the Membrane Localization of FLT3-ITD. Blood. 126(23). 1274–1274.

Polzer, Harald, Hanna Janke, & Stephanie Schneider. (2015). Individualized Treatment Strategy with Small-Molecular Inhibitors in Acute Myeloid Leukemia with Concurrent FLT3-ITD and FLT3-TKD Mutation. Journal of Clinical Case Reports. 5(10). 1 indexed citations

Janke, Hanna, Friederike Pastore, Tobias Herold, et al.. (2014). Activating FLT3 Mutants Show Distinct Gain-of-Function Phenotypes In Vitro and a Characteristic Signaling Pathway Profile Associated with Prognosis in Acute Myeloid Leukemia. PLoS ONE. 9(3). e89560–e89560. 50 indexed citations

Bolck, Hella Anna, Marc Buchwald, Harald Polzer, et al.. (2012). Breakdown of the FLT3-ITD/STAT5 Axis and Synergistic Apoptosis Induction by the Histone Deacetylase Inhibitor Panobinostat and FLT3-Specific Inhibitors. Molecular Cancer Therapeutics. 11(11). 2373–2383. 42 indexed citations

Polzer, Harald, et al.. (2012). Casitas B-lineage lymphoma mutants activate AKT to induce transformation in cooperation with class III receptor tyrosine kinases. Experimental Hematology. 41(3). 271–280.e4. 9 indexed citations

Polzer, Harald, Tobias Herold, Nikola P. Konstandin, et al.. (2012). Exome Sequencing Identifies Recurring FLT3 N676K Mutations in Core Binding Factor Leukemia. Blood. 120(21). 404–404. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact